Accretion Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	896.27	573.76	133.53	293.84	222.92
Other Revenue	1.91	-	-	1.47	2.92
Revenue	898.18	573.76	133.53	295.32	225.84
Revenue Growth (YoY)	56.54%	329.70%	-54.79%	30.76%	-
Cost of Revenue	651.53	400.22	94.36	240.11	179.93
Gross Profit	246.65	173.55	39.17	55.21	45.91
Selling, General & Admin	44.86	37.31	9.09	25.21	19.75
Other Operating Expenses	50.37	17.2	4.27	8.61	6.84
Operating Expenses	107.34	62.26	15.59	43.06	34.7
Operating Income	139.31	111.29	23.58	12.15	11.21
Interest Expense	-8.48	-13.87	-2.57	-10.25	-9.98
Currency Exchange Gain (Loss)	-	0.47	0.11	-	-
Other Non Operating Income (Expenses)	0	-0.25	-1.17	-0.51	-0.19
Pretax Income	130.83	97.64	19.95	1.39	1.04
Income Tax Expense	34.16	29.7	5.02	0.35	0.25
Net Income	96.68	67.94	14.93	1.04	0.79
Net Income to Common	96.68	67.94	14.93	1.04	0.79
Net Income Growth	42.30%	355.08%	1336.77%	31.52%	-
Shares Outstanding (Basic)	11	8	8	-	-
Shares Outstanding (Diluted)	11	8	8	-	-
Shares Change (YoY)	33.57%	5.47%	-	-	-
EPS (Basic)	9.03	8.48	1.96	-	-
EPS (Diluted)	9.03	8.48	1.96	-	-
EPS Growth	6.54%	332.43%	-	-	-
Free Cash Flow	-231.55	41.39	-169.87	-8.57	18.93
Free Cash Flow Per Share	-21.63	5.16	-22.35	-	-
Gross Margin	27.46%	30.25%	29.33%	18.70%	20.33%
Operating Margin	15.51%	19.40%	17.66%	4.12%	4.96%
Profit Margin	10.76%	11.84%	11.18%	0.35%	0.35%
Free Cash Flow Margin	-25.78%	7.21%	-127.22%	-2.90%	8.38%
EBITDA	151.42	119.04	25.81	21.39	19.31
EBITDA Margin	16.86%	20.75%	19.33%	7.24%	8.55%
D&A For EBITDA	12.11	7.75	2.24	9.23	8.1
EBIT	139.31	111.29	23.58	12.15	11.21
EBIT Margin	15.51%	19.40%	17.66%	4.12%	4.96%
Effective Tax Rate	26.11%	30.42%	25.17%	25.14%	24.04%
Revenue as Reported	898.18	574.71	134.07	295.32	225.84
Advertising Expenses	-	0.17	-	0.16	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.